puromycin aminonucleoside has been researched along with Sclerosis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fakhry, I; Gehr, TW; Ghosh, S; Haas, M; Quigg, RJ; Schoolwerth, AC; Sica, D | 1 |
| Fogo, AB; Ma, J; Ma, LJ; Yang, HC | 1 |
| Furuyama, T; Kurosawa, K; Kyogoku, Y; Saito, T; Yamakage, K; Yoshinaga, K | 1 |
| Ebihara, I; Fukui, M; Koide, H; Nakamura, T; Takahashi, T; Tomino, Y | 1 |
| Alvarado, JA; Amato, D; Bobadilla, NA; Calleja, C; Franco, M; García-Torres, R; Herrera-Acosta, J; López, P; Tapia, E | 1 |
5 other study(ies) available for puromycin aminonucleoside and Sclerosis
| Article | Year |
|---|---|
The role of the renin-angiotensin system in cholesterol and puromycin mediated renal injury.
Topics: Angiotensin II; Animals; Cholesterol; Diet; Humans; Kidney Diseases; Kidney Glomerulus; Male; Peptidyl-Dipeptidase A; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Renin-Angiotensin System; RNA, Messenger; Sclerosis | 2002 |
Peroxisome proliferator-activated receptor-gamma agonist is protective in podocyte injury-associated sclerosis.
Topics: Angiopoietin-Like Protein 4; Angiopoietins; Animals; Antibiotics, Antineoplastic; Blood Pressure; Blood Proteins; Body Weight; Drug Evaluation, Preclinical; Glomerular Filtration Rate; Hypoglycemic Agents; Kidney; Male; Pioglitazone; Plasminogen Activator Inhibitor 1; Podocytes; PPAR gamma; Proliferating Cell Nuclear Antigen; Protective Agents; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sclerosis; Thiazolidinediones; Vascular Endothelial Growth Factor A | 2006 |
The effect of protamine on proteinuria and glomerular sclerosis in aminonucleoside nephropathy.
Topics: Animals; Kidney Glomerulus; Male; Nephrotic Syndrome; Protamines; Proteinuria; Puromycin; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains; Sclerosis | 1982 |
Altered glomerular steady-state levels of tumour necrosis factor-alpha mRNA during nephrotic and sclerotic phases of puromycin aminonucleoside nephrosis in rats.
Topics: Acute Disease; Animals; Kidney Glomerulus; Kidney Medulla; Male; Methylprednisolone; Nephrectomy; Nephrosis, Lipoid; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sclerosis; Tumor Necrosis Factor-alpha | 1993 |
Mechanisms involved in the progression to glomerular sclerosis induced by systemic hypertension during mild puromycin aminonucleoside nephrosis.
Topics: Animals; Blood Pressure; Cholesterol; Disease Models, Animal; Hemodynamics; Hypertension, Renovascular; Kidney Glomerulus; Male; Nephrosis; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Wistar; Sclerosis; Triglycerides | 1992 |